AAAAAA

   
Results: 1-7 |
Results: 7
MULTICENTER PROSPECTIVE RANDOMIZED TRIAL OF FLUDARABINE VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (CAP) FOR TREATMENT OF ADVANCED-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: FENAUX P BINET JL LEPORRIER M TRAVADE P PIGUET H LINASSIER C DESABLENS B DREYFUS B BRIZARD CP MURGUE B RUSSET T SOUTEYRAND P JOHNSON S PHILLIPS MJ HIDDEMANN W SMITH A ROATH S LOFFLER H BJORKHOLM M OSBY E EMMERICH B COIFFIER B THIEL E KNAUF W JULIUSSON G MARCUS R PRENTICE AG COPPLESTONE JA FREUND M MILLIGAN PW WINFIELD D YIN J HELLRIEGEL KP HOSSFELD DK KIMBY E BURNETT AK LISTER TA LUCIE N KANZ L LERNER R LINDEMALM C CHILD A HAMBLIN T OSCIER D SMITH JG SINGER RJ PARKER A WHITTAKER J WYLD P SMITH AG
Citation: P. Fenaux et al., MULTICENTER PROSPECTIVE RANDOMIZED TRIAL OF FLUDARABINE VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (CAP) FOR TREATMENT OF ADVANCED-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA, Lancet, 347(9013), 1996, pp. 1432-1438
THE SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF PRANLUKAST IN HEALTHY-VOLUNTEERS
Authors: BROCKS DR UPWARD JW GEORGIOU P STELMAN G DOYLE E ALLEN E WYLD P DENNIS MJ
Citation: Dr. Brocks et al., THE SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF PRANLUKAST IN HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 51(3-4), 1996, pp. 303-308
PHARMACOKINETICS OF NEUTRALASE(TM) (HEPARINASE-I) IN HEALTHY MALE-VOLUNTEERS
Authors: BROUGHTON R ZIMMERMANN J MCINTOSH C CLEMENTI W LEE K WYLD P
Citation: R. Broughton et al., PHARMACOKINETICS OF NEUTRALASE(TM) (HEPARINASE-I) IN HEALTHY MALE-VOLUNTEERS, Anesthesia and analgesia, 82(4), 1996, pp. 1-1
ESTABLISHMENT OF SAFETY AND TOLERABILITY OF NEUTRALASE(TM) (HEPARINASE-I) IN ADULT HEALTHY-MALES
Authors: LEE K WYLD P MCINTOSH C CLEMENTI W BROUGHTON R ZIMMERMANN J
Citation: K. Lee et al., ESTABLISHMENT OF SAFETY AND TOLERABILITY OF NEUTRALASE(TM) (HEPARINASE-I) IN ADULT HEALTHY-MALES, Anesthesia and analgesia, 82(4), 1996, pp. 4-4
HEPARIN REVERSAL WITH NEUTRALASE(TM) (HEPARINASE-I) IN ADULT MALE-VOLUNTEERS
Authors: ZIMMERMANN J MCINTOSH C CLEMENTI W BROUGHTON R LEE K WYLD P
Citation: J. Zimmermann et al., HEPARIN REVERSAL WITH NEUTRALASE(TM) (HEPARINASE-I) IN ADULT MALE-VOLUNTEERS, Anesthesia and analgesia, 82(4), 1996, pp. 93-93
EFFECT OF REPEATED APROSULATE((R)) AND ENOXAPARIN((R)) ADMINISTRATIONON TISSUE FACTOR PATHWAY INHIBITOR ANTIGEN LEVELS
Authors: JESKE W HOPPENSTEADT D KLAUSER R KAMMEREIT A ECKENBERGER P HAAS S WYLD P FAREED J
Citation: W. Jeske et al., EFFECT OF REPEATED APROSULATE((R)) AND ENOXAPARIN((R)) ADMINISTRATIONON TISSUE FACTOR PATHWAY INHIBITOR ANTIGEN LEVELS, Blood coagulation & fibrinolysis, 6(2), 1995, pp. 119-124
SINGLE RISING ORAL DOSE OF SR 27417A, A SPECIFIC PAF RECEPTOR ANTAGONIST IN HUMANS - TOLERABILITY AND PHARMACOLOGICAL ASSESSMENT
Authors: WYLD P NIMMO W HOLLAND T HERBERT JM CLUZEL M
Citation: P. Wyld et al., SINGLE RISING ORAL DOSE OF SR 27417A, A SPECIFIC PAF RECEPTOR ANTAGONIST IN HUMANS - TOLERABILITY AND PHARMACOLOGICAL ASSESSMENT, Journal of lipid mediators and cell signalling, 10(1-2), 1994, pp. 155-157
Risultati: 1-7 |